Monthly ReportOct 1–31, 2026
Sepsis, October 2026 edition
We read 1129 papers and selected 5.
Summary
October 2026 sepsis research showed a decisive shift from uniform protocols toward biologically and physiologically stratified care. Major randomized evidence refined hemodynamic management: intraoperative dobutamine plus norepinephrine reduced postoperative acute kidney injury, whereas lower-threshold vasopressin initiation did not improve mortality. Translational studies converged on immunometabolic and inflammasome pathways, including taurine–NLRP3 signaling, ROS-dependent GSDMD palmitoylation, L-carnitine–pyrin activation, and EZH2 lactylation. Molecular subphenotyping, host–microbe single-cell profiling, rapid diagnostics, and clinically defined sepsis phenotypes continued to advance, although most biomarkers and experimental therapies require prospective validation before routine use. Prevention research also delivered an important negative result, as ExPEC9V failed to prevent invasive Escherichia coli disease despite strong immunogenicity.
Selected Articles
1. Taurine lowers inflammaging by regulating the NLRP3 inflammasome in macrophages.
This study identified taurine as an immunometabolic regulator of NLRP3 inflammasome activation. Danger signals induced taurine efflux from macrophages, whereas taurine restoration suppressed trans-Golgi network disassembly, pyroptosis, and inflammatory signaling. Increasing taurine improved health span and reduced sepsis mortality in aged mice.
Impact: The paper provides a novel mechanistic link between taurine homeostasis, aging biology, inflammasome activation, and sepsis mortality, supported by human observations, cellular experiments, and aged-mouse models.
Clinical Implications: Taurine-based interventions may eventually become adjunctive therapies for inflammasome-dominant sepsis, but optimal dosing, timing, pathogen effects, safety, and human efficacy remain unknown. Clinical use is not currently justified.
Key Findings
- NLRP3 danger signals induced taurine efflux from macrophages as a proximal step in inflammasome activation.
- Taurine restoration suppressed trans-Golgi network disassembly, pyroptosis, and inflammatory signaling.
- Taurine elevation improved health span and reduced sepsis mortality in aged mice.
2. Intraoperative Dobutamine Plus Norepinephrine to Prevent Postoperative Acute Kidney Injury in Septic Shock: A Randomized Clinical Trial.
In this multicenter randomized trial of 584 adults with septic shock undergoing surgical source control, intraoperative dobutamine plus norepinephrine reduced new-onset or worsening postoperative acute kidney injury from 34.7% to 22.8% compared with norepinephrine alone. Stage 2 and stage 3 acute kidney injury were also reduced, although tachycardia occurred more frequently with dobutamine.
Impact: This large multicenter randomized trial directly addressed a guideline-supported intervention previously backed by very low-certainty evidence and provides actionable evidence for perioperative kidney protection.
Clinical Implications: In adults with septic shock undergoing surgical source control, dobutamine added to norepinephrine may reduce postoperative acute kidney injury, particularly when persistent hypoperfusion or cardiac dysfunction is present. Clinicians should balance this potential renal benefit against tachycardia risk and the absence of demonstrated mortality benefit.
Key Findings
- Postoperative new-onset or worsening acute kidney injury occurred in 22.8% with dobutamine plus norepinephrine versus 34.7% with norepinephrine alone.
- Stage 2 and stage 3 acute kidney injury were reduced, with higher early urine output and lower postoperative day 1 SOFA scores in the combination group.
- Tachycardia was more frequent with dobutamine, and mortality or long-term renal benefit was not established.
3. Nanocatalytic Inhibition of ROS-Dependent GSDMD Palmitoylation Mitigates Sepsis Progression.
This mechanistic study identified ROS-driven palmitoylation of GSDMD by ZDHHC5/ZDHHC9 as an amplifier of canonical and non-canonical pyroptosis in sepsis. Vanadium oxide hydroxide nanosheets scavenged ROS, inhibited GSDMD palmitoylation, reduced inflammatory tissue injury, and improved outcomes in two animal models. Human septic-cell observations and GSDMD-knockout experiments supported pathway specificity.
Impact: The study identifies a chemically targetable regulatory step upstream of GSDMD-mediated pyroptosis and combines patient-derived evidence, nanomaterial optimization, multiple animal models, and genetic validation.
Clinical Implications: ROS-scavenging nanocatalysts or selective inhibitors of GSDMD palmitoylation could become adjunctive therapies, but pharmacokinetics, biodistribution, toxicity, effects on pathogen clearance, and therapeutic dosing must be established before human trials.
Key Findings
- GSDMD palmitoylation was increased in peripheral blood mononuclear cells from septic patients and was driven by ROS through ZDHHC5/ZDHHC9.
- Vanadium oxide hydroxide nanosheets inhibited canonical and non-canonical pyroptosis by scavenging ROS and suppressing GSDMD palmitoylation.
- The intervention reduced inflammatory injury and improved outcomes in two animal models, with GSDMD-knockout experiments supporting target specificity.
4. The pyrin inflammasome senses OCTN2-mediated uptake of extracellular ʟ-carnitine from muscle injury or ingestion.
This mechanistic study showed that extracellular L-carnitine activates the pyrin inflammasome after OCTN2-mediated uptake. L-carnitine repressed mevalonate synthesis, and both OCTN2 and pyrin were required for inflammatory responses to skeletal muscle injury. The findings establish a previously unrecognized link between muscle-derived metabolites, sterile inflammation, and innate immune activation.
Impact: The study identifies a highly novel molecular pathway linking muscle injury or dietary L-carnitine to inflammasome activation and provides a new framework for understanding tissue injury-associated inflammation in sepsis.
Clinical Implications: OCTN2, L-carnitine handling, mevalonate metabolism, or pyrin signaling could become therapeutic targets for sterile or sepsis-associated inflammation. Translation requires validation in human sepsis cohorts and clinically relevant infection models.
Key Findings
- Extracellular L-carnitine activated the pyrin inflammasome in LPS-challenged mice and murine and human macrophages.
- OCTN2-mediated uptake and repression of mevalonate synthesis were required for this inflammatory pathway.
- OCTN2 and pyrin were necessary for inflammatory responses to skeletal muscle injury.
5. EZH2 lactylation: a key epigenetic regulator and potential therapeutic target for sepsis-associated lung injury.
Using 209 ICU patients, cecal ligation and puncture models, endothelial-specific Ezh2 knockout mice, pharmacologic interventions, and multi-omics, this study identified site-specific EZH2 K30/K406 lactylation as a lactate-responsive mechanism in sepsis-associated lung injury. EZH2 lactylation reduced EZH2 occupancy at the CITED2 promoter, enhanced NF-kappaB activity, and worsened pulmonary inflammation and endothelial dysfunction. Inhibiting lactate production or EZH2 lactylation improved lung injury in experimental models.
Impact: The paper links a clinically measurable metabolic abnormality, elevated lactate, to a specific post-translational epigenetic modification and a defined inflammatory transcriptional pathway.
Clinical Implications: Lactate kinetics may help identify patients with lactate-driven lung injury, while enzymes or molecular interfaces controlling EZH2 lactylation could become therapeutic targets. However, the patient component is observational and site-specific inhibitors have not been clinically tested.
Key Findings
- Serum lactate was elevated in patients with sepsis-associated lung injury and was associated with inflammatory markers and injury severity.
- EZH2 K30/K406 lactylation increased with disease progression and reduced EZH2 occupancy at the CITED2 promoter.
- Inhibiting lactate production or EZH2 lactylation improved pulmonary function and reduced inflammation, pathological injury, and endothelial dysfunction.